Cogent Biosciences, Inc. COGT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

49/100

2/6 Pass

SharesGrow Intrinsic Value

Cogent Biosciences, Inc. (COGT) has 20 known insider and institutional holders on record. The largest holder is FROST PHILLIP MD ET AL with 15,734,874 shares. Other notable holders include Hsieh Ming and Schulke Ryan.

Over the last 12 months, insiders have made 23 transactions in COGT stock — 17 buys (valued at $29.17M) and 5 sells (valued at $139.58M). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

COGT Insider Ownership

Top Holder

FROST PHILLIP MD ET AL

15,734,874 shares

Buys (12 mo)

$29.17M value

Sells (12 mo)

$139.58M value

12-Month Transaction Activity

Buy 74%

Sell 22%

Top Insider Holders

#	Name	Role	Shares Owned	Last Filed	Relative Size
1	Frost Phillip Md Et Al	10 Percent Owner	15,734,874	2017-12-11	100%
2	Hsieh Ming	Chief Executive Officer	12,259,965	2010-10-12	78%
3	Schulke Ryan	10 Percent Owner, Officer: Chief Executive Officer	6,364,537	2018-04-02	40%
4	Campana Dario	10 Percent Owner	5,045,034	2020-10-08	32%
5	Dubner Derek	Chief Executive Officer	589,513	2017-12-15	4%
6	Reilly James Patrick	President	458,746	2017-10-17	3%
7	Robbins Andrew R	President and CEO	185,000	2025-12-19	1%
8	Wilson Charles	Chief Executive Officer	174,400	2019-04-11	1%
9	Osborne Matthew Scott	Chief Financial Officer	160,400	2020-02-13	1%
10	Ettenberg Seth	Chief Scientific Officer	153,600	2020-02-13	1%
11	Robinson John Edward	Chief Scientific Officer	140,002	2025-12-30	1%
12	Sachs Jessica	Chief Medical Officer	133,938	2025-12-30	1%
13	Green John L.	Chief Financial Officer	131,834	2025-12-30	1%
14	Hodge Geoffrey	Chief Technical Officer	112,400	2020-02-13	1%
15	Kearns Evan	Chief Legal Officer	109,398	2025-12-30	1%
16	Kim Paul	Chief Financial Officer	90,000	2010-05-17	1%
17	Conlin Matthew	10 Percent Owner, Officer: President	80,000	2018-03-29	1%
18	Pinnow Cole	Chief Commercial Officer	65,000	2025-12-19	0%
19	Vasconcelles Michael	Chief Medical Officer	61,900	2019-04-11	0%
20	Booth Bruce	Director	61,338	2020-07-06	0%

Recent Transactions (last 12 months)

Date	Name	Role	Type	Shares	Price	Value
2026-04-01	Ferrante Karen Jean	Director	RSU Award	686	$35.24	$24.17K
2026-03-31	Fairmount Funds Management Llc	Director	Conversion (Sell)	28,000	-	-
2026-01-22	Fairmount Funds Management Llc	Director	Informative Sell	3,500,000	$36.40	$127.4M
2026-01-01	Ferrante Karen Jean	Director	RSU Award	643	$34.74	$22.34K
2025-12-26	Robinson John Edward	Chief Scientific Officer	Informative Sell	90,000	$38.74	$3.49M
2025-12-26	Sachs Jessica	Chief Medical Officer	Informative Sell	82,642	$38.70	$3.2M
2025-12-26	Kearns Evan	Chief Legal Officer	Informative Sell	65,000	$38.70	$2.52M
2025-12-26	Green John L.	Chief Financial Officer	Informative Sell	77,000	$38.68	$2.98M
2025-12-17	Pinnow Cole	Chief Commercial Officer	RSU Award	65,000	$39.45	$2.56M
2025-12-17	Robinson John Edward	Chief Scientific Officer	RSU Award	50,000	-	-
2025-12-17	Sachs Jessica	Chief Medical Officer	RSU Award	50,000	-	-
2025-12-17	Kearns Evan	Chief Legal Officer	RSU Award	40,000	-	-
2025-12-17	Green John L.	Chief Financial Officer	RSU Award	50,000	-	-
2025-12-17	Robbins Andrew R	President and CEO	RSU Award	185,000	-	-
2025-10-01	Ferrante Karen Jean	Director	RSU Award	1,642	$14.13	$23.2K
2025-07-10	Fairmount Funds Management Llc	Director	Informative Buy	2,777,777	$9.00	$25M
2025-07-01	Ferrante Karen Jean	Director	RSU Award	3,314	$7.22	$23.93K
2025-06-04	Cain Christopher W.	Director	RSU Award	44,700	$5.64	$252.11K
2025-06-04	Shegog Todd	Director	RSU Award	44,700	$5.64	$252.11K
2025-06-04	Ros Matthew	Director	RSU Award	44,700	$5.64	$252.11K
2025-06-04	Harwin Peter Evan	Director	RSU Award	44,700	$5.64	$252.11K
2025-06-04	Ferrante Karen Jean	Director	RSU Award	44,700	$5.64	$252.11K
2025-06-04	Morris Arlene	Director	RSU Award	44,700	$5.64	$252.11K